Compare PRPL & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRPL | OM |
|---|---|---|
| Founded | 2010 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.8M | 85.0M |
| IPO Year | N/A | 2020 |
| Metric | PRPL | OM |
|---|---|---|
| Price | $0.74 | $3.40 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $1.00 | ★ $16.00 |
| AVG Volume (30 Days) | 223.4K | ★ 496.7K |
| Earning Date | 11-04-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $457,012,000.00 | $120,069,000.00 |
| Revenue This Year | N/A | $5.77 |
| Revenue Next Year | $12.69 | $9.12 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 4.65 |
| 52 Week Low | $0.56 | $3.10 |
| 52 Week High | $1.29 | $25.35 |
| Indicator | PRPL | OM |
|---|---|---|
| Relative Strength Index (RSI) | 43.10 | 23.48 |
| Support Level | $0.70 | $3.66 |
| Resistance Level | $0.78 | $3.83 |
| Average True Range (ATR) | 0.05 | 0.27 |
| MACD | -0.01 | 0.19 |
| Stochastic Oscillator | 16.42 | 18.36 |
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.